Short Interest in CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Decreases By 29.4%

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 14,400 shares, a decline of 29.4% from the October 15th total of 20,400 shares. Based on an average daily volume of 36,600 shares, the short-interest ratio is presently 0.4 days.

CERo Therapeutics Stock Performance

Shares of NASDAQ CEROW traded down $0.01 during midday trading on Thursday, reaching $0.01. 23,643 shares of the stock were exchanged, compared to its average volume of 54,408. The stock has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.03. CERo Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.25.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.